On ECHEMI
Home > Drugs > Tianjin Golden World Pharmaceutical Co., Ltd.
Tianjin Golden World Pharmaceutical Co., Ltd.
  • Founded in:

    1992-07-03
  • Country:

    China China
  • Address:

    No. 6, Xinghua 9th Road, Xiqing Economic Development Zone, Tianjin
  • Tax NO.:

    9112011160060043XW
  • Registered Funds:

    11.76157 million yuan
  • Email:

Related Drugs
Chlorzoxazone Tablets
Chlorzoxazone
Name Description Content CAS NO. Registered Holders
Chlorzoxazone

Centrally acting muscle relaxants that act on multiple synaptic pathways in the central nervous system to produce muscle relaxants

More

Centrally acting muscle relaxants that act on multiple synaptic pathways in the central nervous system to produce muscle relaxants

95-25-0 19
Aminocachin Tablets
This product is a compound preparation, and its components are: each tablet contains 0.15g of aminopyrine, 0.04g of caffeine, and 0.035g of calcium glycerophosphate.
Name Description Content CAS NO. Registered Holders
Aminopyrine

By inhibiting the synthesis of prostaglandins and other effects, it can eliminate and reduce the activity of pain-causing factors in a multi-target and all-round manner, quickly relieving headaches and neuralgia; it can achieve an antipyretic effect by regulating the hypothalamic temperature regulation center; it can synergize with caffeine to enhance the analgesic effect

More

By inhibiting the synthesis of prostaglandins and other effects, it can eliminate and reduce the activity of pain-causing factors in a multi-target and all-round manner, quickly relieving headaches and neuralgia; it can achieve an antipyretic effect by regulating the hypothalamic temperature regulation center; it can synergize with caffeine to enhance the analgesic effect

0.15g 0
Caffeine

Enhance the analgesic effect, enhance the excitement process of the cerebral cortex, invigorate the spirit, and improve symptoms such as fatigue, discomfort and lack of energy caused by headaches and neuralgia

More

Enhance the analgesic effect, enhance the excitement process of the cerebral cortex, invigorate the spirit, and improve symptoms such as fatigue, discomfort and lack of energy caused by headaches and neuralgia

0.04g 0
CALCIUM GLYCEROPHOSPHATE

As a neurotrophic drug, it improves the activity of nerve tissue, enhances nerve nutrition, promotes the metabolism of nerve tissue, restores its normal physiological function, and has a therapeutic effect on neurasthenia and memory loss.

More

As a neurotrophic drug, it improves the activity of nerve tissue, enhances nerve nutrition, promotes the metabolism of nerve tissue, restores its normal physiological function, and has a therapeutic effect on neurasthenia and memory loss.

0.035g 27214-00-2 4
Pidotimod Granules
(R)-3-[(S)-(5-oxo-2-pyrrolidinyl)-carbonyl]-thiazolidinyl-4-carboxylic acid
Name Description Content CAS NO. Registered Holders
(R)-3-[(S)-(5-oxo-2-pyrrolidinyl)carbonyl]-thiazolidinyl-4-carboxylic acid

This product is a synthetic oral immunopotentiator that works by stimulating and regulating cell-mediated immune responses.

More

This product is a synthetic oral immunopotentiator that works by stimulating and regulating cell-mediated immune responses.

0
(R)-3-[(S)-(5-oxo-2-pyrrolidinyl)-carbonyl]-thiazolidinyl-4-carboxylic acid

This product is a synthetic oral immunopotentiator that works by stimulating and regulating cell-mediated immune responses.

More

This product is a synthetic oral immunopotentiator that works by stimulating and regulating cell-mediated immune responses.

0
Inosine Tablets
Each tablet of this product contains 0.2 grams of the main ingredient inosine, and the auxiliary materials are starch, dextrin and sugar.
Name Description Content CAS NO. Registered Holders
Inosine

Participate in cell energy metabolism and protein synthesis in the body, increase the activity of related metabolic enzymes, improve liver function, and promote the recovery of damaged liver

More

Participate in cell energy metabolism and protein synthesis in the body, increase the activity of related metabolic enzymes, improve liver function, and promote the recovery of damaged liver

0.2g 58-63-9 8
Starch

Inosine participates in cellular energy metabolism and protein synthesis in the body, increases the activity of related metabolic enzymes, improves liver function, and promotes the recovery of damaged liver.

More

Inosine participates in cellular energy metabolism and protein synthesis in the body, increases the activity of related metabolic enzymes, improves liver function, and promotes the recovery of damaged liver.

9005-25-8 79
Dextrin

Inosine participates in cellular energy metabolism and protein synthesis in the body, increases the activity of related metabolic enzymes, improves liver function, and promotes the recovery of damaged liver.

More

Inosine participates in cellular energy metabolism and protein synthesis in the body, increases the activity of related metabolic enzymes, improves liver function, and promotes the recovery of damaged liver.

9004-53-9 49
sugar

Inosine participates in cellular energy metabolism and protein synthesis in the body, increases the activity of related metabolic enzymes, improves liver function, and promotes the recovery of damaged liver.

More

Inosine participates in cellular energy metabolism and protein synthesis in the body, increases the activity of related metabolic enzymes, improves liver function, and promotes the recovery of damaged liver.

0
Captopril Tablets
Captopril.
Name Description Content CAS NO. Registered Holders
Captopril

This product is a competitive angiotensin converting enzyme inhibitor, which prevents angiotensin I from being converted into angiotensin II, thereby reducing peripheral vascular resistance and reducing water and sodium retention by inhibiting aldosterone secretion. This product can also dilate peripheral blood vessels by interfering with the degradation of bradykinin. For patients with heart failure, this product can also reduce capillary wedge pressure and pulmonary vascular resistance, increase cardiac output and exercise tolerance time.

More

This product is a competitive angiotensin converting enzyme inhibitor, which prevents angiotensin I from being converted into angiotensin II, thereby reducing peripheral vascular resistance and reducing water and sodium retention by inhibiting aldosterone secretion. This product can also dilate peripheral blood vessels by interfering with the degradation of bradykinin. For patients with heart failure, this product can also reduce capillary wedge pressure and pulmonary vascular resistance, increase cardiac output and exercise tolerance time.

62571-86-2 28
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.